Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Lithium-Ketamine Therapy in Bipolar Depression
NCT01768767Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Jan 2013
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ketamine in bipolar disorder (BD), sponsored by Yale University. Planned start Jan 2013; status: withdrawn.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01768767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768767.